Literature DB >> 7581246

Screening of polyacetylenic alcohols in crude drugs using the ELISA for panaxytriol.

T Saita1, M Katano, H Matsunaga, I Kouno, H Fujito, M Mori.   

Abstract

Polyacetylenic alcohols such as panaxytriol, panaxynol and panaxydol isolated from the roots of Panax ginseng C. A. MEYER have antiproliferative activity against various cultured tumor cells. Anti-panaxytriol antibody was obtained by immunizing rabbits with panaxytriol-bovine serum albumin conjugates. Although the antibody reactivity was directed mainly toward panaxytriol, there was a slight cross-reactivity with other polyacetylenic compounds. The antibody was, therefore, used for screening a large number of crude drugs for polyacetylenic compounds such as panaxytriol. Methanol-extracts from 31 crude drugs were examined. Significant reactivity was observed in 15 methanol-extracts from Aralieaceae, Compositae and Umbelliferae as reported by other investigators. Three out of the 15 crude drugs were selected for determination of the potent cross-reactive compounds. Four kinds of cross-reactive compounds were isolated by silica gel column chromatography, monitoring each fraction using the enzyme-linked immunosorbent assay (ELISA). Among them, panaxynol and heptadeca-1,8-diene-4,6-diyne-3,10-diol were identified from Saposhnikoviae Radix. Falcarindiol was newly identified from Peucedani Radix. A new polyacetylenic alcohol, 9,10-epoxy-16-hydroxy-octadeca-17-ene-12,14-diyne-1-al, was also isolated from Foeniculi Fructus. All these polyacetylenic alcohols inhibited the growth of a human gastric adenocarcinoma cell line, MK-1 cells, in a dose-dependent manner. These results indicate that the antibody against panaxytriol is an effective tool for "screening" antiproliferative polyacetylenic compounds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581246     DOI: 10.1248/bpb.18.933

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

Review 1.  Anticancer activity of natural and synthetic acetylenic lipids.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2006-10       Impact factor: 1.880

2.  Multifaceted cytoprotection by synthetic polyacetylenes inspired by the ginseng-derived natural product, panaxytriol.

Authors:  Ting-Chao Chou; Huajin Dong; Xiuguo Zhang; Xiaoguang Lei; John Hartung; Yandong Zhang; Jun Hee Lee; Rebecca M Wilson; Samuel J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

3.  Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations.

Authors:  Constance Lay Lay Saw; Anne Yuqing Yang; David C Cheng; Sarandeep S-S Boyanapalli; Zheng-Yuan Su; Tin Oo Khor; Song Gao; Jingrong Wang; Zhi-Hong Jiang; Ah-Ng Tony Kong
Journal:  Chem Res Toxicol       Date:  2012-08-09       Impact factor: 3.739

4.  Enantioselective ProPhenol-catalyzed addition of 1,3-diynes to aldehydes to generate synthetically versatile building blocks and diyne natural products.

Authors:  Barry M Trost; Vincent S Chan; Daisuke Yamamoto
Journal:  J Am Chem Soc       Date:  2010-04-14       Impact factor: 15.419

5.  (3R, 9R, 10R)-Panaxytriol: A molecular-based nutraceutical with possible application to cancer prevention and treatment.

Authors:  Fay Ng; Heedong Yun; Xiaoguang Lei; Samuel J Danishefsky; Jed Fahey; Katherine Stephenson; Charles Flexner; Lawrence Lee
Journal:  Tetrahedron Lett       Date:  2008-12-08       Impact factor: 2.415

6.  Total synthesis of (3R,9R,10R)-panaxytriol via tandem metathesis and metallotropic [1,3]-shift as a key step.

Authors:  Eun Jin Cho; Daesung Lee
Journal:  Org Lett       Date:  2007-12-13       Impact factor: 6.005

7.  Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways.

Authors:  Constance Lay-Lay Saw; Qing Wu; Ah-Ng Tony Kong
Journal:  Chin Med       Date:  2010-10-27       Impact factor: 5.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.